Therapixel Completes €15M Series B Financing to Deploy MammoScreen® 2D/3D
will accelerate the commercial deployment of its Artificial Intelligence reading solution for 2D/3D mammography, with a focus on the United States
Read Morewill accelerate the commercial deployment of its Artificial Intelligence reading solution for 2D/3D mammography, with a focus on the United States
Read MoreAcquisition adds innovative bioabsorbable steroid-eluting sinus implants to ENT portfolio
Read MorePulsenmore’s handheld tele-ultrasound device docks with a smartphone, allowing women to perform ultrasound self-scans at home and receive fast clinical feedback from healthcare professionals
Read MoreThe goal is to enable the best possible patient care by making data available to healthcare staff to make quick and accurate decisions for patients
Read MoreThe funds will be used to commercialise its cardiology technology and commence the first-in-human clinical study of Ceryx’s cardiac rhythm management device, Cysoni, later this year
Read MoreThe collaboration will enable AI-powered decentralized clinical trials
Read MoreGE Healthcare and RaySearch aim to enable hospitals and cancer treatment centers to implement an interoperable and integrated workflow that will optimize their clinical planning and operational outcomes
Read MoreRENOVA iStim™ implantable tibial neuromodulation device is being studied as a minimally invasive, patient-centric solution for the treatment of overactive bladder (OAB)
Read Morea ten-year strategic partnership and R&D alliance to bring cutting edge cancer treatment to patients
Read MoreAcquisition strengthens IBA’s Dosimetry operations in North America and adds one of the most comprehensive dosimetry “phantom” offerings on the market
Read More